SCHEMBL6173479

SCHEMBL6173479

CC(c1ccncc1NNC(=O)c1ccccc1)C1(C(C)c2ccncc2NNC(=O)c2ccccc2)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.44
GAA P10253 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
TLR7 Q9NYK1 2/20 0.37
F2R P25116 1/20 0.35
GSK3A P49840 1/20 0.34
GSK3B P49841 1/20 0.34
LMNA P02545 1/20 0.34
HDAC3 O15379 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC2 Q92769 1/20 0.34
NAMPT P43490 1/20 0.34
TRPV1 Q8NER1 2/20 0.34
KDM5A P29375 1/20 0.33
KDM4C Q9H3R0 1/20 0.33
KDM5B Q9UGL1 1/20 0.33
PDE2A O00408 1/20 0.33
GPR132 Q9UNW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174515 0.92 ALDH1A1 (0.45) ALDH1A1GAACYP3A4CYP2C9CYP2C19
SCHEMBL6177570 0.87 ALDH1A1 (0.40) ALDH1A1GAACYP3A4CYP2C9CYP2C19
SCHEMBL6172844 0.85 CYP3A4 (0.40) ALDH1A1GAACYP3A4CYP2C9CYP2C19
SCHEMBL6172977 0.85 CYP3A4 (0.43) ALDH1A1GAACYP3A4CYP2C9CYP2C19
SCHEMBL6175907 0.85 ALDH1A1 (0.39) ALDH1A1GAACYP3A4CYP2C9CYP2C19
SCHEMBL6173454 0.84 CYP2C9 (0.41) ALDH1A1GAACYP3A4CYP2C9CYP2C19
SCHEMBL6175217 0.84 GAA (0.42) ALDH1A1GAACYP3A4CYP2C9CYP2C19
SCHEMBL6278206 0.83 TRPV1 (0.49) ALDH1A1NAMPTTRPV1KDM5AKDM4C
SCHEMBL6173573 0.83 CACNA1H (0.41) ALDH1A1GAACYP3A4CYP2C9CYP2C19
SCHEMBL6174642 0.83 ALDH1A1 (0.42) ALDH1A1GAACYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed